Lupus Trials: What's Key to Lowering Placebo Response Rates?
High placebo response rates in lupus clinical trials are making it difficult to show treatment effectiveness.
Stay updated with breaking news from Patient Selection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
High placebo response rates in lupus clinical trials are making it difficult to show treatment effectiveness.
Autologous stem cell transplant reduced the risk for relapses, compared with fingolimod and natalizumab, in a recent analysis.
The Society for Cardiovascular Angiography and Interventions releases draft guidance on the adoption of renal denervation for hypertension in anticipation of regulatory approval.
A randomized controlled trial questions the value of routine perioperative palliative care consultation in patients with cancer undergoing major curative-intent surgery.
People with type 2 diabetes and a cortisol-secreting adrenal mass had worse glycemic control compared with those with type 2 diabetes and a nonfunctioning adrenal mass.